Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

OPK
Opko Health Inc.
stock NASDAQ

At Close
Aug 29, 2025 3:59:55 PM EDT
1.38USD-2.817%(-0.04)1,663,921
0.00Bid   0.00Ask   0.00Spread
Pre-market
Aug 29, 2025 9:22:30 AM EDT
1.36USD-4.056%(-0.06)12,959
After-hours
Aug 29, 2025 4:47:30 PM EDT
1.39USD+0.725%(+0.01)15,219
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 27, 2022
08:15AM EST  Opko Health Reports In Form4 Filing Frost Gamma Investments Trust Buys 350K Shares At Average Price Of $2.98   Benzinga
Jan 24, 2022
02:34PM EST  Mid-Afternoon Market Update: Nasdaq Down 250 Points; OPKO Health Shares Plunge   Benzinga
12:38PM EST  Mid-Day Market Update: Dow Dips 1000 Points; Exterran Shares Jump   Benzinga
10:05AM EST  Benzinga's Top Ratings Upgrades, Downgrades For January 24, 2022   Benzinga
08:32AM EST  Barrington Research Downgrades OPKO Health to Market Perform   Benzinga
08:21AM EST  Benzinga Pro's Top 5 Stocks To Watch For Monday, Jan. 24, 2022: UL, SNAP, OPK, M, IBM   Benzinga
06:11AM EST  A Peek Into The Markets: US Stock Futures Down Following Friday's Plunge   Benzinga
Jan 21, 2022
05:38PM EST  Shares of OPKO Health, Inc. (OPK) slipped nearly 10% in after-hours trading on Friday after the U.S. Food and Drug Administration issued a Complete Response Letter for the Biologics License Application for somatrogon.   RTTNews
04:31PM EST  Pfizer, OPKO Health Report FDA Issued Complete Response Letter For Biologics License Application For Their Somatrogon   Benzinga
04:30PM EST  Pfizer and OPKO Provide Update on the Biologics License Application for Somatrogon for Pediatric Growth Hormone Deficiency   Business Wire
Jan 20, 2022
08:12AM EST  Japan's Ministry Of Health, Labour And Welfare Approves Pfizer And OPKO's NGENLA (Somatrogon), A New Long-Acting Treatment For Pediatric Growth Hormone Deficiency   Benzinga
08:00AM EST  Japans MHLW Approves Pfizer and   GlobeNewswire Inc
Jan 18, 2022
09:39AM EST  Sema4 Strengthens AI-Driven Genomic, Clinical Data Platform With $623M GeneDx Acquisition   Benzinga
07:00AM EST  Business combination projected to deliver $350 million in pro forma 2022 revenue   GlobeNewswire Inc
Jan 5, 2022
04:05PM EST  OPKO Health to Participate in the 40th Annual J.P. Morgan Healthcare Conference   Business Wire
Dec 23, 2021
01:56PM EST  Opko Health Posts Data From COVID-19 Trial With Its Kidney Disease Treatment   Benzinga
08:29AM EST  OPKO Health Inc. (OPK) announced preliminary positive results from its Phase 2 trial with Rayaldee to treat mild-to-moderate COVID-19. The preliminary data indicated that vitamin D repletion therapy can mitigate the severity of upper respiratory tract infections and accelerate recovery from COVID-19.   RTTNews
08:10AM EST  OPKO Health Announces Topline Results From Phase 2 Trial Of RAYALDEE To Treat COVID-19 Outpatients   RTTNews
08:02AM EST  OPKO Health Announces Topline Results From Phase 2 Trial Evaluating RAYALDEE To Treat Symptomatic COVID-19 Outpatients   Benzinga
08:00AM EST  OPKO Health, Inc. (NASDAQ: OPK) announces preliminary topline results from its Phase 2 trial with RAYALDEE to treat mild-to-moderate COVID-19. This study builds on increasing medical evidence that vitamin D repletion therapy can mitigate the severity of upper respiratory tract infections and accelerate recovery from COVID-19.   GlobeNewswire Inc
Dec 20, 2021
11:01AM EST  OPKO Health Option Alert: Mar 18 $5 Calls Sweep (19) above Ask!: 1902 @ $0.35 vs 4523 OI; Earnings 2/17 After Close [est] Ref=$4.4   Benzinga
Dec 14, 2021
08:17AM EST  OPKO Biologies Granted U.S. Patent #11,197,915 'Long-acting polypeptides and methods of producing and administering same'   Benzinga
Dec 8, 2021
08:03AM EST  OPKO Health Reports Received US FDA Approval For 4Kscore Test   Benzinga
08:00AM EST  OPKO Health Receives U.S. FDA Approval for the 4Kscore   GlobeNewswire Inc
Dec 6, 2021
08:00AM EST  OPKO Health Announces the Passing of Director Dr. Richard Lerner   GlobeNewswire Inc
Nov 30, 2021
04:04PM EST  OPKO Health's BioReference Laboratories Announces Readiness For COVID-19 Testing If Omicron COVID-19 Variant Emerges In U.S   Benzinga
Nov 29, 2021
10:25AM EST  BioReference Laboratories Announces Readiness for COVID-19 Testing if the   PR Newswire
08:00AM EST  OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in the Piper Sandler 33rd Annual Virtual Healthcare Conference taking place November 30 through December 2, 2021. A pre-recorded company fireside chat is available for registered attendees via the Piper Sandler conference site and at this link.   GlobeNewswire Inc
Oct 28, 2021
05:02PM EDT  OPKO Health Q3 Adj. EPS $0.00   Benzinga
04:24PM EDT  OPKO Health Q3 EPS $0.04 Beats $(0.01) Estimate, Sales $385.80M Beat $302.27M Estimate   Benzinga
04:08AM EDT  Earnings Scheduled For October 28, 2021   Benzinga
Oct 25, 2021
10:57AM EDT  OPKO Health to Report Third Quarter 2021 Financial Results on   GlobeNewswire Inc
Oct 13, 2021
01:38PM EDT  Taysha Gene Therapies Announces Sponsored Genetic Testing For Giant Axonal Neuropathy In Partnership With GeneDx As Well As A Collaboration with Hereditary Neuropathy Foundation And Charcot-Marie-Tooth Association Centers Of Excellence   Benzinga
Oct 12, 2021
08:09AM EDT  Krystal Biotech and GeneDx Announce Collaboration To Provide No-Charge Genetic Testing For Patients With Suspected Dystrophic Epidermolysis Bullosa   Benzinga
08:00AM EDT  Krystal Biotech and GeneDx Announce Collaboration to Provide   GlobeNewswire Inc
Oct 5, 2021
02:08PM EDT  2-23-10 Small Cap Market News and Stock Highlights from SmallCapVoice.com   Benzinga
Sep 27, 2021
06:43AM EDT  The following are some of the stocks making big moves in Monday's pre-market trading (as of 6.15 A.M. EDT).   RTTNews
Sep 24, 2021
04:25PM EDT  Pfizer and OPKO Announce Extension of U.S. FDA Review of Biologics License Application of Somatrogon for Pediatric Growth Hormone Deficiency   Benzinga
04:24PM EDT  Pfizer and OPKO Announce Extension of U.S. FDA Review of Biologics   GlobeNewswire Inc
Sep 21, 2021
02:30PM EDT  GeneDx Announces the Sequencing of More Than 300,000 Clinical Patient Exomes   PR Newswire
Sep 20, 2021
11:09AM EDT  OPKO Health Option Alert: Dec 17 $4 Calls Sweep (5) near the Ask: 953 @ $0.398 vs 1741 OI; Earnings 10/28 After Close [est] Ref=$3.86   Benzinga
Sep 14, 2021
08:13AM EDT  LeaderMed Group And OPKO Form Joint Venture To Develop And Commercialize Oxyntomodulin And Factor VIIa-CTP In China And Other Asian Territories; Opko To Grant JV Rights To OPK88003 And Factor VIIa-CTP For 47% JV Interest And $1M Upfront Payment   Benzinga
08:00AM EDT  LeaderMed Group and OPKO Health Form Joint Venture to Develop and   GlobeNewswire Inc
Aug 31, 2021
08:15AM EDT  The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical   Benzinga
Aug 30, 2021
04:18PM EDT  OPKO Health Completes Enrollment In Phase 2 Trial Evaluating RAYALDEE As A Treatment For Symptomatic COVID-19 Outpatients   Benzinga
04:17PM EDT  OPKO Health Completes Enrollment in Phase 2 Trial Evaluating   GlobeNewswire Inc
09:05AM EDT  OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in two upcoming virtual investor conferences.   GlobeNewswire Inc
Aug 26, 2021
09:21AM EDT  Rite Aid Announces 'Back To School' COVID-19 Testing Program   RTTNews
09:18AM EDT  Rite Air Reports Partnership With US Dept. Of Health And Human Services, BioReference Labs, New York State For 'Back To School' COVID-19 Testing Program   Benzinga
09:18AM EDT  Rite Aid, in Partnership with the U.S. Department of Health and Human Services, BioReference Laboratories and New York State, Announces 'Back to School' COVID-19 Testing Program   Business Wire
Aug 16, 2021
09:58AM EDT  OPKO's BioReference Laboratories Acquires U.S. Ariosa Centralized Laboratory Prenatal Testing Business From Roche; Terms Not Disclosed   Benzinga
09:57AM EDT  BioReference Labs Buys U.S. Ariosa Centralized Laboratory Prenatal Testing Business   RTTNews
09:56AM EDT  BioReference Laboratories Acquires U.S. Ariosa Centralized Laboratory Prenatal   PR Newswire
08:36AM EDT  Opko Health Form 4 Filing Shows Purchase Of 100K Shares By Frost Gamma Investments Trust   Benzinga
Jul 29, 2021
04:47PM EDT  OPKO Health Q2 EPS $(0.03) Misses $0.02 Estimate, Sales $442.40M Miss $456.36M Estimate   Benzinga
08:18AM EDT  The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs   Benzinga
04:23AM EDT  Earnings Scheduled For July 29, 2021   Benzinga
Jul 25, 2021
10:05AM EDT  The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More   Benzinga
Jul 20, 2021
08:00AM EDT  OPKO Health to Report Second Quarter 2021 Financial Results on   GlobeNewswire Inc
Jul 12, 2021
10:59AM EDT  OPKO Health, CAMP4 Therapeutics Ink Oligonucleotide Platform With Focus On Drug-Resistant Epilepsy   Benzinga
08:13AM EDT  OPKO Health Licenses Oligonucleotide Therapeutics Platform To CAMP4 Therapeutics; OPKO Eligible To Receive Up To $93.5M And Additional Shares Upon Achievement Of Certain Development And Sales Milestones   Benzinga
08:00AM EDT  OPKO Health Licenses Oligonucleotide Therapeutics Platform to   GlobeNewswire Inc
Jul 8, 2021
04:05PM EDT  OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in the Ladenburg Thalmann Healthcare Conference being held virtually July 13-14, 2021. Management will be interviewed in a fireside chat format on Tuesday, July 13th at 8:30 a.m. Eastern time and will also be holding one-on-one virtual meetings with investors throughout the day.   GlobeNewswire Inc
Jun 22, 2021
08:25AM EDT  OPKO Health Appoints Katherine Stueland As President And CEO Of GeneDx   RTTNews
07:45AM EDT  BioReference Laboratories Announces First COVID-19 Testing Program For Cruise Industry   RTTNews
07:40AM EDT  OPKO's BioReference Laboratories Announces COVID-19 Testing Program For Royal Caribbean Group   Benzinga
07:40AM EDT  BioReference Laboratories Announces First COVID-19 Testing Program for Cruise   PR Newswire
Jun 21, 2021
11:01AM EDT  OPKO Health, Nicoya Therapeutics Ink Rayaldee Pact For Hyperparathyroidism In Greater China   Benzinga
10:15AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2021   Benzinga
08:29AM EDT  OPKO Health Enters Agreement With Nicoya Macau To Develop RAYALDEE In Greater China   RTTNews
08:16AM EDT  OPKO Health Enters Agreement With Nicoya Macau Limited To Develop, Commercialize RAYALDEE In China   RTTNews
08:04AM EDT  OPKO Health To Develop And Commercialize RAYALDEE In Greater China With Nicoya Therapeutics   Benzinga
08:03AM EDT  OPKO Health to Develop and Commercialize RAYALDEE in   GlobeNewswire Inc
07:22AM EDT  Ladenburg Thalmann Initiates Coverage On OPKO Health with Buy Rating, Announces Price Target of $7   Benzinga
Jun 17, 2021
08:25AM EDT  OPKO Health Offloads Fill and Finish Manufacturing Facility in Ireland To Horizon Therapeutics   Benzinga
07:02AM EDT  OPKO Health Announces SaleOf iIs Sterile Fill And Finish Manufacturing Facility In Ireland To Horizon Therapeutics For $65M   Benzinga
07:00AM EDT  OPKO Health Announces Sale of its Sterile Fill and Finish   GlobeNewswire Inc
May 28, 2021
08:00AM EDT  Cocrystal Pharma Announces the Passing of Chairman, CEO and   GlobeNewswire Inc
May 27, 2021
08:30AM EDT  OPKO Health, Inc. (NASDAQ: OPK) announced today that management will be participating in the Jefferies Virtual Healthcare Conference being held June 1-4, 2021. Management will be interviewed in a fireside chat on Wednesday, June 2 at 11:30 a.m. Eastern time and will also be holding one-on-one virtual meetings with investors throughout the day.   GlobeNewswire Inc
May 24, 2021
07:32AM EDT  OPKO Health Reports Transfer Of Licensed Rights to RAYALDEE In Japan To Vifor   Benzinga
07:30AM EDT  OPKO Health, Inc. (NASDAQ: OPK) today announced a transfer of the licensed rights to RAYALDEE in Japan from Japan Tobacco Inc. (JT) to Vifor Fresenius Medical Care Renal Pharma (VFMCRP).   GlobeNewswire Inc
May 18, 2021
03:41PM EDT  OPKO Health Option Alert: Jan 21 $4 Calls Sweep (12) near the Ask: 499 @ $0.84 vs 18250 OI; Ref=$3.61   Benzinga
May 7, 2021
01:34PM EDT  OPKO Health, Inc. (NASDAQ: OPK) has entered into exchange agreements with certain noteholders of the Companys 4.50% Convertible Senior Notes due 2025 (Notes). The noteholders have agreed to exchange $55.42 million of the Companys outstanding 2025 Notes for shares of the Companys common stock.   GlobeNewswire Inc
Apr 28, 2021
05:28PM EDT  OPKO Health: Q1 Earnings Insights   Benzinga
04:36PM EDT  OPKO Health Q1 EPS $0.05, Inline, Sales $545.20M Beat $498.46M Estimate   Benzinga
04:05PM EDT  OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended March 31, 2021.   GlobeNewswire Inc
07:26AM EDT  The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping   Benzinga
04:15AM EDT  Earnings Scheduled For April 28, 2021   Benzinga
Apr 27, 2021
08:43AM EDT  Major League Soccer Renews With OPKO's BioReference Laboratories As COVID-19 Testing Provider   Benzinga
08:38AM EDT  Major League Soccer Renews with BioReference Laboratories as COVID-19 Testing   PR Newswire
Apr 24, 2021
09:24AM EDT  The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx   Benzinga
Apr 22, 2021
08:00AM EDT  OPKO Health to Report First Quarter 2021 Financial Results on   GlobeNewswire Inc
Apr 1, 2021
08:30AM EDT  OPKO's BioReference Laboratories Announces COVID-19 Testing Agreement Tor MLB; Financial Details Not Disclosed   Benzinga
08:28AM EDT  BioReference Laboratories Expands Its Major League Sports Relationships with   PR Newswire
Mar 30, 2021
05:19AM EDT  OPKO Biologics Awarded U.S. Patent 10,960,058 'Long-acting coagulation factors and methods of producing same'   Benzinga
Mar 26, 2021
08:26AM EDT  OPKO's BioReference Labs Reports Expansion Of Its COVID-19 School Testing Program To Support Return To In-Person Classroom Instruction Across US   Benzinga
08:25AM EDT  BioReference Laboratories Expands COVID-19 School Testing Program   PR Newswire
Mar 9, 2021
11:06AM EST  Insider Buys OPKO Health's Stock   Benzinga
Feb 26, 2021
07:29AM EST  Pfizer Inc. (PFE) and OPKO Health Inc. (OPK) announced Friday that the European Medicines Agency or EMA has validated for review the Marketing Authorization Application for somatrogon. Pfizer expects a decision from the European Commission in 2022.   RTTNews
06:31AM EST  Pfizer, OPKO Health Report EMA Validates For Review Marketing Authorization Application For Somatrogon For Pediatric Patients With Growth Hormone Deficiency   Benzinga
Feb 22, 2021
01:03PM EST  OPKO Health shares were trading higher after the company announced it would participate in the New York Forward Rapid Testing Program.   Benzinga
11:51AM EST  Insider Buys OPKO Health's Shares   Benzinga
09:34AM EST  ROCE Insights For OPKO Health   Benzinga
08:43AM EST  OPKO's BioReference Laboratories To Participate In NY Forward Rapid Testing Program, Opens Eight COVID-19 Rapid Testing Locations Around New York   Benzinga
Feb 19, 2021
07:25AM EST  The Daily Biotech Pulse: Novavax Vaccine Supply Deal, Orphan Drug Designation For Travere, COVID-19 Boost For Quidel, Opko   Benzinga
06:14AM EST  Opko Health's Q4 Service Revenues More Than Double Due To COVID-19 Testing Services   Benzinga
Feb 18, 2021
04:38PM EST  OPKO Health: Q4 Earnings Insights   Benzinga
04:13PM EST  OPKO Health Q4 EPS $0.05 Beats $0.04 Estimate, Sales $494.60M Beat $443.10M Estimate   Benzinga
04:05PM EST  OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended December 31, 2020.   GlobeNewswire Inc
11:41AM EST  Earnings Preview for OPKO Health   Benzinga
08:14AM EST  The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout   Benzinga
04:28AM EST  Earnings Scheduled For February 18, 2021   Benzinga
Feb 17, 2021
10:11AM EST  Earnings Preview for OPKO Health   Benzinga
Feb 3, 2021
09:01AM EST  OPKO Health to Report Fourth Quarter 2020 Financial Results on   GlobeNewswire Inc
Jan 28, 2021
08:03AM EST  OPKO Health Reports Partner, Pfizer Japan, New Drug Application Submitted To Japan's Ministry Of Health, Labour, Welfare For Somotrogon Human Growth Hormone   Benzinga
08:00AM EST  OPKO Health, Inc. (NASDAQ: OPK) announced today that its partner, Pfizer Japan Inc., submitted a New Drug Application (NDA) to the Ministry of Health, Labour, and Welfare in Japan for somatrogon, a long-acting recombinant human growth hormone that is intended to be administered once-weekly for the treatment of pediatric patients with growth hormone deficiency (GHD).   GlobeNewswire Inc
Jan 26, 2021
08:39AM EST  OPKO Health's BioReference Labs Joins Hands With NBA And NHL To Provide Players And Staff With COVID-19 Testing   RTTNews
08:34AM EST  OPKO Health's BioReference Labs' GeneDx Reports Launch Of Several New Genetic Tests For Ataxia   Benzinga
08:31AM EST  of Spinocerebellar Ataxia (SCA), Friedreich Ataxia, and Other Common Forms of Hereditary Ataxia   PR Newswire
08:13AM EST  OPKO Health's BioReference Labs Reports COVID-19 Testing Deals For Players, Officials During NBA, NHL   Benzinga
08:03AM EST  Association and National Hockey League to Provide Players and Staff with COVID-19 Testing   PR Newswire
Jan 17, 2021
03:18PM EST  Cramer Shares His Thoughts On American Airlines, American Tower And More   Benzinga
Jan 13, 2021
03:40PM EST  OPKO Health's BioReference Laboratories Introduces Scarlet Health(tm), an   PR Newswire
06:02AM EST  OPKO Health Shareholder, Sian Capital, Sends Letter To Co. Urging Address Of 'Apparently Misleading Q4 Guidance'   Benzinga
06:00AM EST  Sian Capital Urges OPKO Health to Address Apparently Misleading   GlobeNewswire Inc
Jan 11, 2021
08:31AM EST  Aviceda Therapeutics Announces Formation of Executive Team   Benzinga
Jan 5, 2021
08:00AM EST  OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in the 39th Annual J.P. Morgan Healthcare Conference being held virtually on January 11-14, 2021. Management will be hosting one-on-one meetings with investors and will be presenting on Wednesday, January 13th at 3:40 p.m. Eastern time.   GlobeNewswire Inc
Jan 4, 2021
12:06PM EST  OPKO Health's BioReference Laboratories Reports Results Of Largest COVID-19 Public School Testing Program Nationwide   Benzinga
12:06PM EST  OPKO Health Reports Its BioReference Labs Unit Reported REsults Of COVID-19 Molecular PCR Tests For Public Schools Throughout New York City's Boroughs   Benzinga
12:05PM EST  OPKO Health's BioReference Laboratories Reports Results of the Largest COVID-19   PR Newswire
07:02AM EST  Pfizer Inc. (PFE) and OPKO Health Inc. (OPK) announced FDA has accepted for filing the initial Biologics License Application for somatrogon, a long-acting human growth hormone for the treatment of pediatric patients with growth hormone deficiency. The target PDUFA action date for decision by the FDA is in October 2021.   RTTNews
06:49AM EST  Pfizer: FDA Accepts For Filing The Initial BLA For Somatrogon To Treat Pediatric Patients With Growth Hormone Deficiency   RTTNews
06:49AM EST  US FDA Accepts Regulatory Submission from Pfizer and OPKO for Review of Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency   Benzinga
Dec 31, 2020
08:43AM EST  Buffalo Bills And OPKO Health's BioReference Labs Initiate First Large Scale, Mandatory COVID-19 Fan Testing Program   RTTNews
08:32AM EST  OPKO's BioReference Labs Reports Buffalo Bills, Co. Have Initiated First Large-Scale, Mandatory COVID-19 Fan Testing Program   Benzinga
08:31AM EST  Buffalo Bills and OPKO Health's BioReference Laboratories Initiate the First   PR Newswire
Dec 29, 2020
08:14AM EST  OPKO CEO Frost Bought 300,000 Shares @ Avg Price of $4.00/Share as Reported in Form 4 Filing   Benzinga
Dec 21, 2020
08:00AM EST  OPKO Health, Inc. (NASDAQ: OPK) today announced the appointment of Roger Medel, M.D. as an independent member of its Board of Directors, effective December 18, 2020. With this appointment, the OPKO Health Board has 11 Directors, including seven independent Directors.   GlobeNewswire Inc
Dec 6, 2020
04:45PM EST  Cramer Gives His Opinion On Boeing, Fiverr And More   Benzinga
Nov 20, 2020
04:46PM EST  Sian Capital Sends Letter to OPKO Health Regarding its Decision to Apparently Withhold Rayaldee From Many Patients Amidst COVID-19's Second Wave   Benzinga
04:45PM EST  BelievesOPKO Should PromptlyDistributeFDA-ReviewedRayaldee to Help Treat COVID-19 in theU.S. and Europe   GlobeNewswire Inc
Nov 14, 2020
01:45PM EST  Last Week's Notable Insider Buys: Kraft, IBM, Vertex And More   Benzinga
Nov 11, 2020
09:11AM EST  OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in three upcoming virtual investor conferences.   GlobeNewswire Inc
Nov 10, 2020
11:25AM EST  Insider Buys OPKO Health's Shares   Benzinga
Oct 30, 2020
11:36AM EDT  ROCE Insights For OPKO Health   Benzinga
08:09AM EDT  The Daily Biotech Pulse: Novavax Vaccine Data, Axovant Flags Delay In Parkinson's Study, 2 Biotechs Make Wall Street Debuts   Benzinga
Oct 29, 2020
05:36PM EDT  OPKO Health Shareholder, Sian Capital, Issues Press Release Highlighting Viable Paths For Co. To Unlock Shareholder Value   Benzinga
04:43PM EDT  OPKO Health: Q3 Earnings Insights   Benzinga
04:29PM EDT  OPKO Health Q3 EPS $0.04, Inline, Sales $428.10M Beat $374.36M Estimate   Benzinga
07:30AM EDT  The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal   Benzinga
04:08AM EDT  Earnings Scheduled For October 29, 2020   Benzinga
Oct 26, 2020
11:55AM EDT  OPKO Health Option Alert: Mar 19 $4 Calls at the Ask: 363 @ $1.15 vs 16471 OI; Earnings 10/29 After Close Ref=$4.35   Benzinga
Oct 20, 2020
08:06AM EDT  OPKO Health's BioReference Laboratories Launches Multiplex COVID-19 and Influenza A/B Test   Benzinga
08:02AM EDT  OPKO Health's BioReference Laboratories Launches Multiplex COVID-19 and   PR Newswire
Oct 13, 2020
12:51PM EDT  OPKO Health to Report Third Quarter 2020 Financial Results on   GlobeNewswire Inc
Oct 9, 2020
08:07AM EDT  OPKO Health's BioReference Laboratories Launches COVID-19 Testing Program For New York City Schools   RTTNews
08:01AM EDT  OPKO Health's BioReference Laboratories Launches COVID-19 Testing Program for   PR Newswire
08:01AM EDT  OPKO's BioReference Labs Highlights Launch Of COVID-19 Testing Program For New York City Schools Throughout 2020-2021 School Year   Benzinga
Oct 8, 2020
10:41AM EDT  Why OPKO Health's Stock Is Trading Higher Today   Benzinga
09:08AM EDT  Common Stock during the period of September 26, 2013 through September 7, 2018   PR Newswire
06:53AM EDT  Pfizer And OPKO Announced The Phase 3 Results for Once-Weekly Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency Met Its Primary Endpoint Of Improved Treatment Burden   Benzinga
Oct 2, 2020
09:48AM EDT  OPKO Health Option Alert: Jan 15 $4 Calls Sweep (6) near the Ask: 329 @ $0.85 vs 9303 OI; Earnings 11/3 After Close [est] Ref=$3.8884   Benzinga
Sep 15, 2020
07:03AM EDT  OPKO Health Initiates Clinical Trial Of RAYALDEE In COVID-19 Patients   Benzinga
Sep 2, 2020
04:05PM EDT  OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in two upcoming virtual investor conferences.   GlobeNewswire Inc
03:18PM EDT  Why Opko Health's Stock Is Trading Higher Today   Benzinga
08:12AM EDT  OPKO Health's BioReference Laboratories Announces New York City Schools COVID-19 Testing Program   Benzinga
08:08AM EDT  OPKO Health's BioReference Labs Announces New York City Schools COVID-19 Testing Program   RTTNews
08:01AM EDT  OPKO Health's BioReference Laboratories Announces New York City Schools   PR Newswire
Sep 1, 2020
03:55PM EDT  OPKO Health's BioReference Laboratories Launches Best-in-Class Next-Generation   PR Newswire
Aug 28, 2020
03:52PM EDT  OPKO Health Option Alert: Jan, 2022 $7 Calls Sweep (50) near the Ask: 518 @ $0.63 vs 10276 OI; Ref=$3.3   Benzinga
Aug 24, 2020
10:14AM EDT  OPKO Health Shares Volatile; Jim Cramer Tweets 'Bioreference --HUGE GET NFL false positives?? I don't know.. Watch @MadMoneyOnCNBC tonight'   Benzinga
Aug 17, 2020
10:35AM EDT  'Dr. Scott Gottlieb touts Yale's new saliva coronavirus test developed in conjunction with NBA' -CNBC Report   Benzinga
08:50AM EDT  Opko Health Shares Spike Higher; Hearing Jim Cramer Mentions Co On CNBC   Benzinga
Aug 14, 2020
10:33AM EDT  Cramer Advises His Viewers On Fleetcor, Tupperware And More   Benzinga
Aug 12, 2020
12:04PM EDT  ROCE Insights For OPKO Health   Benzinga
09:16AM EDT  OPKO Health's BioReference Labs Subsidiary, GeneDx, Reports Deal With Pediatrix Medical Group To Offer Neonatal Genomic Services, No Terms Disclosed   Benzinga
09:16AM EDT  OPKO Health's GeneDx Enters into Agreement with Pediatrix Medical Group to   PR Newswire
Aug 6, 2020
09:27AM EDT  OPKO Health's GeneDx Adds GenomeXpress To Clinical Genomics Portfolio   Benzinga
08:01AM EDT  OPKO Health's GeneDx Adds GenomeXpress to Its Industry-Leading Clinical   PR Newswire
Aug 5, 2020
03:36PM EDT  OPKO Health, Inc. (NASDAQ: OPK) today announced that management will participate in a fireside chat at the BTIG Virtual Biotechnology Conference on Monday, August 10, 2020 at 9:00 a.m. Eastern time. In addition, management will be hosting one-on-one meetings with investors via organized conference calls.   GlobeNewswire Inc
Jul 31, 2020
09:34AM EDT  OPKO Health Option Alert: Aug 7 $7 Calls Sweep (5) near the Ask: 1019 @ $0.25 vs 4722 OI; Ref=$5.69   Benzinga
Jul 30, 2020
04:23PM EDT  OPKO Health Q2 EPS $0.05 Up From $(0.10) YoY, Sales $301.20M Beat $245.60M Estimate   Benzinga
04:06AM EDT  Earnings Scheduled For July 30, 2020   Benzinga
Jul 27, 2020
11:23AM EDT  Why Opko Health's Stock Is Trading Higher Today   Benzinga
08:00AM EDT  OPKO Health to Report Second Quarter 2020 Financial Results on   GlobeNewswire Inc
Jul 24, 2020
10:15AM EDT  OPKO Health Option Alert: Sep 18 $5 Calls Sweep (4) near the Ask: 397 @ $1.22 vs 8877 OI; Earnings 8/5 After Close [est] Ref=$5.2982   Benzinga
Jul 20, 2020
02:48PM EDT  OPKO Health's BioReference Laboratories Awarded Commercial Surge Capacity Testing For Coronavirus Emergency Response Contract by CDC   Benzinga
02:45PM EDT  Testing for COVID-19 Emergency Response Contract by Centers for Disease Control and Prevention (CDC)   PR Newswire
05:11AM EDT  80 Biggest Movers From Friday   Benzinga
Jul 13, 2020
03:35PM EDT  OPKO Health shares are trading higher after the company announced its BioReference Laboratories will provide COVID-19 testing for NBA players and employees. UPDATE: Shares have since reversed, now lower.   Benzinga
08:11AM EDT  OPKO Health's BioReference Laboratories To Provide COVID-19 Testing For National Basketball Association Players And Employees   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC